Browsing by Author Henderson, Michelle

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2013ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome AtlasdeFazio, Anna; Emmanuel, Catherine; Gao, Bo-Fu; Beesley, Johnathan; Chen, Xiaoqing; et al, Various; Fereday, Sian; Hedditch, Ellen; Henderson, Michelle; Johnatty, Sharon E.; Law, Matthew; Lu, Yi; Russell, Amanda; Webb, Penelope M.; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas, Gynecologic Oncology, vol.131, 1, 2013,pp 8-14
2008The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitrode Fazio, Anna; Murali, Rajmohan; Scolyer, Richard; Scurr, Lyndee; Barton, C; Davies, Michael; et, al; Gloss, B; Henderson, Michelle; O'Brien, P; Patterson, K I; Saunders, D; Scurry, J; Smith, Alison N.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Pathology; Central Clinical School: Pathology; Western Clinical School: Medicine (Westmead)The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro, British Journal of Cancer, vol.98,(6),2008,pp 1085-1093
2015Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerdeFazio, Anna; Gao, Bo; Harnett, Paul; Beesley, Jonathan; Chen, Xiao Qinq; et, al; French, Juliet; Henderson, Michelle; Hillman, Kristine M; Johnatty, Sharon; Kalimutho, Murugan; Kar, Siddhartha; Lu, Yi; Russell, Amanda; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Medicine (Westmead)Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer, Oncotarget, vol.7, 6, 2015,pp 6353-6368
2014Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancerBalleine, Rosemary; deFazio, Anna; Emmanuel, Catherine; Gao, Bo-Fu; Harnett, Paul; Wong, Ka (Mark); Beesley, Jonathan; Bowtell, David D L; Chen, Xiao Qinq; Chenevix-Trench, Georgia; Galletta, Laura; Haber, Michelle; Healey, Sue; Henderson, Michelle; Johnatty, Sharon E.; Norris, Murray D.; Russell, Amanda; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer, Scientific Reports, vol.4, N/A, 2014,pp 1-9
2017Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivoByrne, Jennifer; Allan, Sophie; Cheung, Leanna; Eden, Georgina L.; Flemming, Claudia L.; Fletcher, J; Gamble, Laura; Gifford, Andrew J; Haber, M; Hanssen, Kimberley M.; Henderson, Michelle; Murray, J; Norris, Murray; Ruhle, Michelle; Saletta, Federica; Schuetz, John D.; Tan, Alvin; Tivnan, Amanda; Truong, Alan M.; Valli, Emanuele; Yu, Denise; Childrens Hospital Westmead: Paediatrics & Child HealthSuppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo, European Journal of Cancer, vol.83, N/A, 2017,pp 132-141